The SMAC-mimetic xevinapant differentially enhances cisplatin and immune checkpoint blockade efficacy in high-risk HPV-positive tumors.

xevinapant (Debio 1143) - EMD Serono

cisplatin - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42235210

Abdullah A Osman; Arisa Nishikawa Kaga; Jeffrey N Myers; Kento Okamoto; Mutsuki Kawabe; Tsung-You Tsai

Jun 4, 2026